<DOC>
	<DOCNO>NCT00414752</DOCNO>
	<brief_summary>The purpose study assess safety efficacy AFQ056 nicotine compare placebo crave withdrawal symptom voluntary smoking stoppage healthy smoker . This study also assess body interacts AFQ056 .</brief_summary>
	<brief_title>Effects AFQ056 Nicotine Reducing Cigarette Smoking</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy , male &amp; female subject least 18 year ≤60 year age In good health Female subject must surgically sterilize postmenopausal . Current smoker intend quit Smoke average 15 cigarettes less 60 cigarette day past year Fagerström Test Nicotine Dependence score least 5 ( indicates moderate heavy smoker ) Willing refrain smoking require Written informed consent enter study History heart disease , septum defect and/or cardiac valve surgery ; clinical relevant abnormality ECG Investigational drug treatment within 4 week prior screen unless local health authority guideline mandate longer period Women childbearing potential , pregnant lactating female Donation one unit ( 400mL ) blood , significant blood loss equal least one unit blood within past 2 month blood transfusion within 8 week prior screen . Coffee consumption 6 cup coffee/day Use medication within 2 week prior Day 1 treatment period Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Smoking , abstinence , crave , smoker , AFQ056 , nicotine , placebo</keyword>
</DOC>